ECENT monographs and a rapidly expanding literature1-4 indicate the interest and large amount of experimental work on the effects of hormones on lipid metabolism and atherosclerosis. The present paper reviews some of these data not with the purpose of dealing exhaustively with the available information but rather to provide the reader with a digestible summary.
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The Thyroid Gland
Myxedema is frequently cited as a condition demonstrating a relation between hormonally induced hypercholesteremia and atherosclerosis. Since this presumed relation has been one of the strongest pillars in the hypercholesteremia theory of atherogenesis, the evidence requires careful evaluation.
A wealth of clinical and human experimental observation indicates a potent influence of the thyroid gland on the metabolism of cholesterol and other lipids. Blood cholesterol, serum phosphatides, and fatty acids are increased in myxedema.5' 6 In cretinous children, a high ratio of free to total serum cholesterol has been described.7 In adults with myxedema, however, normal or increased ester :total cholesterol ratio occurs. The rise in serum cholesterol is greater than that of phospholipid, and the cholesterol:phospholipid ratio is increased.8 An increase of lowdensity (beta) lipoproteins, both in spontaneous and in induced myxedema, is largely in the Sf 0-12 moiety but is found also in fractions Sf 464 may be reversed with very small doses of desiccated thyroid (15 to 30 mg.)."-Similar findings are reported in most aninial studies: hypercholesteremia accompanies decreased thyroid function whether this results from surgical extirpation,12 113' radiation,'3 or thiourea administration.4 The domestic pig is a notable exception.'5 The mechanism of the hypercholesteremia has been explained by studies in animals and man. In hyperthyroidism, the serum cholesterol falls in the face of increased cholesterol synthesis, due to increased bile acid excretion (particularly chenodesoxycholic acid). Conversely, in hypothyroidism, cholesterol synthesis is depressed, but bile acid excretion is also decreased; there is a slow turnover of the serum cholesterol, which is elevated apparently because excretion is depressed more than synthesis. Despite the changes in serum cholesterol, available evidenee indicates that there is no change in the total body pool of cholesterol in myxedema.
Does myxedema lead to atherosclerosis and is there a relation of the alterations of lipid metabolism in myxedema to atherosclerosis? The evidence is derived from studies of patients with untreated myxedema and cretinism and from studies in experimentally induced hypothyroidism in aiinials. Since the peak ineidence of myxedema occurs at a time when spontaneous atherosclerosis is common, studies attributing atherosclerosis to adult myxedema must be interpreted with caution. Moreover, some of the cases repeatedly cited as evidence for a relation of myxedema to atherosclerosis have been complicated by hypertension and renal disease, conditions which themselves predispose to atheroselerosis.'9 Of interest ini this regard is the classic report of the Committee of the Clinical Society of London based on aii extensive inivestigation of the subject of niyxedema.20 It noted that "arterial degeneration, indeed, does niot appear to Circulation, Volume XXII, September 1960 exist to any unusual extent, at any rate in the larger vessels." Relevant also are our own studies in adults with rheumatic heart disease and severe congestive failure in whom therapeutic total thyroidectomy was carried out.21 None of the 8 cases studied by us showed significant coronary atherosclerosis 1 to 13 years after surgical induction of hypothyroidism and its consequent elevated serum cholesterol. Subsequently, careful study with the injection-dissection technic has been made of the hearts of 2 additional patients aged 33 and 45 with multivalvular rheumatic heart disease and chronic congestive heart failure in whom myxedema was induced with 1131.
Again, despite clear hypothyroidism with elevated serum cholesterol for 1 to 4 years, no complete occlusions or significant coronary narrowing was found. It should be noted, however, that these patients received doses (15 to 30 mg.) of desiccated thyroid, which have been shown to alter serum lipoprotein patterns. These data do not disprove a role of cholesterol in the production of human coronary atherosclerosis. They do suggest that the relation of hypothyroidism to adult atherosclerosis requires further documentation. The finding of a high incidence of atherosclerosis in young patients with hypothyroidism would offer more substantial support for a relation between these conditions. While clear cases have been reported of extensive atherosclerosis in cretins and patients with juvenile myxedema,22 such findings are by no means universal. There have also been reported youthful myxedematous subjects in whom no atherosclerosis existed and, indeed, in whom arteries were described as "delicate. "23 It would be of great value to know what factors differentiate the fate of those whose vessels were extensively involved and those free of involvement.
While the clinical evidence correlating myxedema, hypercholesteremia, and atherosclerosis is conflicting, experimental evidence in animals is more consistent. Thus, in rabbits, rats, cockerels, and dogs the combination of thyroid depression (as by thiourea) and cho-Circulation, Volume XXII, September 1960 lesterol feeding has usually resulted in atherosclerosis. Indeed, in resistant species, such as the rat and the dog, the addition of thiourea to cholesterol feeding is one of the few methods leading to persistent hypercholesteremia and atherosclerosis.24 In cholesterol-fed cockerels, hypothyroidism counteracts the ability of estrogens to inhibit coronary atherogenesis. 25 Conversely, thyroid feeding inhibits diet-induced hypercholesteremia and atherosclerosis. Even these experimental data, however, must be regarded with some reservations. Thus, in other studies, feeding thyroid hormones to chicks revealed a conspicuous limitation and inconsistency of its effect. At most hypercholesteremia and atherogenesis were only partially inhibited and in some experiments only minimal effects were noted, despite high dosage. Moreover, large doses of desiccated thyroid inhibited the regression of atherosclerosis that occurs when cholesterolfed chicks are returned to a plain mash diet. Furthermore, thiourea has been shown to produce more extensive effects than mere thyroid depression; athyreotic thiouracil-treated rats have a higher serum cholesterol than athyreotic controls and liver cholesterol in the former group was 50 per cent higher than in the controls.' Finally, while hypercholesteremia in excess of 450 mg. per cent for 1 year appears requisite to atherogenesis, similar hypercholesteremia in 1131 treated dogs not fed cholesterol does not lead to atheroma formation. 26 In summary, thyroid depression accompanied by cholesterol feeding will result in marked hypercholesteremia for prolonged periods and atherogenesis in most species. However, mere reduction in thyroid function without cholesterol feeding, yielding only moderate elevation of serum cholesterol, is not a sufficient condition for consistent atherogenesis. Thus, the respective roles of hypothyroidism and hypercholesteremia in atherosclerosis remain to be clarified.
The plasma lipid abnormalities that exist in the hypothyroid state are readily reversed by the administration of thyroid. Significant depression of serum cholesterol, of the cholesterol phospholipid ratio, and of the beta-lipoprotein cholesterol can be noted even after smnall doses of thyroid that still leave a hypometabolic state. As a natural extension of this observation, efforts have been made to reduce the cholesterol of euthyroid persons with desiccated thyroid. Unfortunately, large doses of up to 325 mg. of thyroid daily are required to produce a persisteint reduction in elevated serum lipids.27 Such large doses of thyroid are not, however, suitable for administration to patients with coronary disease, euthyroid or hypothyroid, because they may increase metabolic requirements enough to reduce exercise tolerance and provoke angina pectoris.
Consequently, an intensive search has beeni nmade for a thyroxine derivative that would decrease plasma cholesterol without inereasing total body (and particularly cardiac) rnetabolism. Early enithusiasm for the efficaey of Triac, the acetic acid analogue of triiodothyronine, waned when it was shown to precipitate angina pectoris and diminiished exercise toleraniee although total body metabolic rate remained unchaniged.28 29 Moreover, the fall in plasma cholesterol produced by Triae in euthyroid hypercholesteremic nmen with coronarv disease could not be maintained even with increased dosage. Other thyroactive agents that have been tried experimentally or clinically inielude the propioniie and formic acid derivatives of thyroxine and triiodothyronine. In myxedematous patienits and euthyroid patienits with hypercholesteremia, administratioii of triiodothyropropionlic acid in appropriate dosage reduced serum cholesterol up to 32 per cent with inerease of basal nietabolic rate of only 4 to 7 per eent.30' 3 Iinvestigation of other coimpounds such as diiodothyroaeetic acid (DIAC), 33'5' triiodothyroninie, and its derivatives is still in the preliminary stages. Since the chief calorigenie activity of thyroxine exists in its 1-isomer, it has beeii suggested that a hypocholesterenmie effect without metabolic stimulation might be achieved by the use of the d-isoinier. At presemit, d-thyroxine32 and d-triiodothyroniiie are uuder active study. In appropriate dosage, these agents have some hypoeholesteremic effect before elevation of total body metaboic rate. A number of questions, however, rermain to be answered with each: 1. In patients with coronary artery disease, is there exacerbationl or precipitation of cardiae svymiptoms with altered cardiac metabolism 2. What is the degree of reduction of serumL (cholesterol an(d does it persist? 3. In the event that a satisfactory answer is found to the first 2 questions, what influenlee does such a hypoeholesteremicn effect have oii the iiatuLral history of atherosclerosis in mnan?
Sex Hormones
While some doubt exists concerninog the influence of altered thyroid state on atherogenesis in man, the evidence is inore convineiing that the sex hormones play a role in the development of arteriosclerosis, particularly of the coronarv arteries. There is a higher inicidence of angina pectoris and acute mnyoeardial infaretioni due to coronary disease in mren than in women. The early studies of Schlesinger and Zoll33 showed a frequeney of coronary occlusionis in iiei six times that of women in the age group 40 to 59 and two times in the age group 60 to 79. A larger series of 1,011 conisecutive hearts injected, dissected, and x-rayed according to the method of Schlesinger was analyzed bv Wessler (personal communication) with respect to the sex and age incideiiee of coronary artery disease. Approximatelv 50 per cent of this series had iio symnptomus referable to the heart, iior was heart disease the cause of death. The percentage of men hav7ing complete occlusion of one or more major arteries was twice that of wvomen in the fourth, fifth, and sixth decades but only a third greater in. the seventlth and eighth decades. Ani anralysis of the incideTnce of narrowvinig (wwhere the cross-sectional lumeni of the major arterv was reduced 50 to 75 per eenit) similarly demonostrat;ed a higher frequency in miien than in women up to the sixth decade. In the later decades, the inicidence in women was equal to that in men.
Several studies have now shown that bilat-eral oophorectomy in the young woman increases the incidence and severity of coronary artery disease.34 37 Wuest et al. compared the degree of coroniary atherosclerosis in 49 hearts from women bilaterally oophorectonmized 2 to 42 years before death to that in 1,200 hearts from mien and wonmeni of conmparable ages and found significantly more coronary sclerosis in the bilaterally oophorectomized womnan thain in comitrol women, but less thamn in the control ntieni. It is interesting that only a small percentage of the women had clinical evidence of coronary artery disease. The small series was not unusually weighted with hypertelnsive patients nior was there any apparent relation of imutrition to the degree of coronary atherosclerosis. While no unusual increase in elinieal incidence of diabetes mellitus was observed, the possibility cannot be comnpletely excluded, since glucose tolerance tests were apparently nlot carried out. Rivin and Dimitroff35 studied the arteries of patients who died from cancer, some of whomiwere treated with estrogens or were subjected to bilateral oophorectomy. Theyfound increased atherosclerosis in the castrated female subjects and decreased coronary atherosclerosis in the mnen treated with estrogen and in the women with hyperestrogenism. A recent study by Oliver and Boyd36 of 200 women, who had had a unilateral oophoreetoiny or hysterectomy with bilateral oophoreetonmy 20 years before, confirms the influence of bilateral oophorectomy on the development of coronary artery disease. Coronary artery disease had developed in one quarter of the women who had bilateral oophorectomy and in only 1 of 31 patients who had unilateral oophorectomy. An interesting current study iii the Bantu provides additional evidenee in this regard. 38 The Bantu has been shown to have a low incidence of death from coronary artery disease. 39 There is no sex differenee in severity of arteriosclerosis or in mortality rate from vascular lesions. It has been observed that the male Bantu has a high estrogen excretion and a high incidenee of gynecomastia and cirrhosis of the liver. Moreover, Circulation, Volume XXII, September 1960 in the Bantu, cholesterol levels are equal in both sexes and do not rise after the age of 30 to 40. Although atherosclerosis is present and may be severe, acute coronarv oeelusioii occurs infrequently.
In western populations, serum cholesterol in the female is lower than in the male until the sixth decade when cholesterol levels become higher thaii those of the male.40 Bilateral oophorectomy results in an elevation of the serum cholesterol and of the cholesterol :phospholipid iatio. Robinson et al. also found an inerease in serum lipids after bilateral oophorectomy in patients with overt coroniary artery disease. 41 With the exception of Engelberg and Glass,42 4 many investigators have now found that estrogen administration results, in both men and women, in a decrease in serum cholesterol, a decreased cholesterol :phospholipid ratio, a decrease in the beta-lipoproteini cholesterol, and an inerease in the alpha-lipoprotein cholesterol.44 4 The changes in serum cholesterol occur promptly, within 1 or 2 wveeks after relatively large doses of estrogen, anid are sustained as long as therapy is adlministered.48 49 As nloted above, the phospholipid changes are muore marked thain the cholesterol changes. As with most agents, the cholesterol fall is greatest in those instances in which initial values are highest. Following cessation of therapy, there may be a rebounid.
Estrogens are also effective in reducing total and esterified cholesterol, phospholipids, triglycerides, and total lipids in idiopathic hyperlipemias.50
The mechanism of the estrogen effect in decreasing the serum cholesterol has not beeni elucidated. In some species, estrogen decreases cholesterol biosynthesis, while in others, a stinmulating effect is observed. It is known that estrogen increases thyroid activity anid may result in an increased serum proteinbound iodine. In pregnancy, however, there is ani increase in serum cholesterol rather than a decrease. Another effect of estrogeln is to stimulate reticuloendothelial activity,51 shown by Friedman, Byers, and Rosenman to have a significant influence in clearing the blood of cholesterol. 52 The protective effects of oral or parenteral estrogens in preventing coronary atheromatosis in cholesterol-fed cockerels has been demonstrated by Katz et al. Estrogens induced the following alterations: feminization, increase in the ratio of free to total plasma cholesterol (FC/TC), enhanced hyperphospholipemia with lowering of the ratio of plasma total cholesterol to lipid phosphorus (C/P) to normal levels, depression of alphalipoprotein levels, reduction of Sf 20 -100 + levels, and prevention of coronary atherogenesis without influencing formation of aortic lesions.3 25 Estrogen also reversed the coronary lesions induced by feeding cholesterol. Androgen prevented the feminization while not affecting the decreased cholesterol: phospholipid ratio induced by estrogens or altering the protection afforded the coronary arteries.
There are striking species differences in the response of serum cholesterol to sex hormones. The female rat has a higher serum cholesterol than the male; cholesterol levels are higher in the pre-estrous to estrous phase and fall off thereafter.53 Testosterone lowers the serum cholesterol and other lipids in the female rat. In the male rat, estradiol stimulates cholesterol synthesis and increases serum cholesterol; conversely, testosterone lowers serum cholesterol. Oophorectomy decreases the cholesteremic response of cholesterol-fed rabbits and rats.54 Testosterone lowers serum cholesterol in female rabbits, whereas estrogen therapy of male and female rabbits fed cholesterol caused an exaggerated rise in serum cholesterol.
In view of such species differences, caution must be exercised in the transfer of any of these results to man. The clinical usefulness of estrogen therapy is limited in man by side effects including gynecomastia, decreased libido, and weakness, with histologic evidence of testicular atrophy and fibrosis.47 55, 5 Moreover, such therapy in men who have already suffered one myocardial infaretion does not appear to reduce the incidence of angina pectoris or the frequency of a second acute myocardial infaretion, nor does it appear to prolong life. In the postmenopausal woman, estrogen therapy has little effect upon seruni cholesterol. Further data are necessary, however, to determine the effects of estrogen on vascular disease in such persons. It thus appears that estrogen therapy should be restricted to the young woman in whom bilateral oophorectomy has been performed.
The search for other substances with hypocholesteremic but less estrogenic effect is under active pursuit. One such substance,57
Manvene (a 3,16-substituted estriol derivative) has less estrogenic side effects, but recent reports indicate that this agent alters liver function significantly. A new agent, MER 29, triparanol, related to TACE, a synthetic estrogen, does reduce serum cholesterol and is without estrogenic effect.58 It apparently interferes with cholesterol production late in the biosynthetic pathway. Ani increase in the liver and blood of a cholesterol precursor, 24-dehydrocholesterol or desmosterol, following triparanol therapy has been showni by Avigan et al. 59 Desmosterol gives a color in the Lieberman-Burchard reaction which is less intense than cholesterol. Consequently, the reduction in total serum sterol is less than would be indicated by the standard methods of cholesterol determination. Whether desmosterol has an effect similar to cholesterol on atherogenesis remains to be determined.
The effects of testosterone and related substances on atherosclerosis in man require additional study. Testosterone does not have a favorable effect on angina pectoris; the initial reports indicating benefit have not been confirmed. Although testosterone produces iu) change in total serum cholesterol, there is a reduction in alpha-lipoprotein cholesterol and an increase in the beta-lipoprotein cholesterol following testosterone or methyl testosterone. The androgens abolish completely the effects of estrogen on serum cholesterol and lipoproteins in man but have very little effect on the feminizing capacity of estrogens.45 A possible Circulation, Volume XXII, September 1960 therapeutic effect of derivatives of androgenis is suggested, however, by the data of Hellmani et al. 60 They have shown a distinet hypocholesteremic effect following the administrationl of etiocholanalone and androsterone. Further studies will undoubtedly be fortheominig with these and related substances.
Adrenal Cortex Evidence of the effects of adrenial cortical hormnones on eirculating lipid and on the development of atherosclerosis is conflicting. Observations in experimental animals are not in agreement with those obtained in human patients with a variety of pathologic conditions in whom hormones were used for therapeutic purposes. Studies on normal human subjects are limited. Species differences in circulating lipids and lipoproteins limit the applicability of animal experiments to man. 61 Clinical observation62 has suggested that hyperfunction of the adrenal cortex (Cushing 's syndrome) produces hypercholesteremia and an abnormnal distribution of body fat, whereas adrenal cortical insufficiency is associated with a low serum cholesterol and a loss of body fat. Similarly, adrenaleetomized dogs maintained on desoxyeorticosterone acetate (DOCA) suffer a progressive decrease in plasma phospholipid and cholesterol. The administration of cortisone after DOCA withdrawal has led to a rapid restoration of serum lipids. 63 However, when either corticotrophin or cortisone acetate was administered intramuscularly to ambulatory men with high plasma cholesterol and coronary artery disease, the plasma cholesterol, the total cholesterol: phospholipid ratio, and beta-lipoprotein cholesterol fell and the alpha-lipoprotein cholesterol rose. 64 Conn and Vogel also showed a drop in serum cholesterol levels during short-term administration of corticotrophin.05 In eontrast, Adlersberg et al. 66 reported that when cortisone was administered to 18 patients severely ill with a variety of clinical conditions, there was an increase of total and esterified cholesterol and phospholipid and a decrease in serum neutral fat. Only 4 of the 18 ill pa-Circulation, Volume XXII, September 1969 tients had serum cholesterol levels above 250 ing. per cent and, in these, there was no change after cortisone therapy. Bloom and Pierce adminiistered corticotrophin to 9 patients and noted a decrease of serum cholesterol without chanige in the ester ratio.67 The effect of cortisone was less consistent. In 6 patients receiving short-terni corticotrophinand cortisone therapy and in 8 of 9 patients un-dergoing longY-tern-cortisone therapy, they noted no trend in Sf 10-20 lipoprotein or serum cholesterol."8
In the normal rabbit, administrationi of corticotrophini and cortisonle results in lipemia, inereased serum lipoproteins Sf 80-400, and smaller quanitities of Sf 40-80. After cessation of cortisone, there is a serial conversion of the larger to smaller lipoprotein until normally occurring Sf 3-12 results. Moreover, the combined adminlistration of cortisonie and cholesterol feeding resulted in enihaneed levels of all lipid fractions comnpared with cholesterol feeding alone.69 In chickens, hydrocortisone and long-acting corticotrophini produced diabetes and enihaneenieit of hypercholesteremia although cortisonie wvas relatively inaetive. 70 Interest in the influenlee of the adrenal cortex on circu'atinig lipids is enihanced because of the relation of the adrenal eortex to stress.
A number of stressful situations (surgery, starvation, infection) in man and animal have been shown to result in a decrease in serum cholesterol.7' Relief of stress after steroid therapy of serious disease has been suggested as the cause of the resulting rise of cholesterol.72 On the other hand, an increased serum cholesterol has been showni in medical students at the time of examination and in accountanits during tax periods.73' 74 The influence of steroids, hypercholesteremia, and stress oln humani atherogenesis remains obscure. It has beein suggested that hunman beings with hyperadrenocorticism frequently develop premature severe atheroselerosis.62 If so, the relative role of hypertension, diabetes, and lipids has not been clarified. In the rabbit and chick, the hyperlipen-ia and 46') hypercholestereinia occurring after administrationi of cortisone, hydrocortisonie, anid corticotrophin has been assoeiated with the deposition of significantly less arterial lipid than in control cholesterol-fed animals.75 This suggests that in the rabbit other factors (i.e., the state of the ground substance) than hypercholestereniia anid its duration exert ani influence oni atlherogenesis. On the other hand, studies in rats suggest that stress may enihanee the development of atheroseler osis.71
Adrenal Medulla
The effect of stress oni serum lipids may I)e mediated not only through the adrenal cortex but also through the adrenal medulla and the sympathetic nervous systein. The effect mnay be primeary or the result of a seconidary release brought about by a specific pituitary mobilizing factor. Norepinephrine and epinephrinie incirease eirculatory levels of free fatty acids in mani anid in dogs.77 7 Prolonged injections of epiniephrine result ini a rise in serunm cholesterol and phospholipid with a smualler anid variable response in triglycerides. There is also an-i inierease in the d=1.019 to 1.063 anid in the d=1.063 to 1.21 lipoprotein fraections. Both tlhe fatty acid and lipoprotein responses to epinephrine are abolished or markedly reduced in adrenalectomnized rats and dogs, anid the normal response is restored by cortisoine. Thus, inereased secretion of both adrenal mnedullary and cortical hormon-ies nmay be inportanit in the hypercholesteremia of stress.
Pituitary Gland
Most of the hormlones of the pituitary glaiid exert an effect on lipids through their respective end organs. Thus, the effects of cortico- ,lands in atherogenesis. The evidence is stronogest that estrogens play a role in humani atherosclerosis. The influence of hypothyroidism requires further study and clarificationi. Hornioles and lipids are obviously not the onily factors iinportant in atherogenesis; hypertension, local tissue factors, and altered initravascular eoagulation iii all probabilitv significantly influeniee the niatural history of the disease.
Summario in Interlingua
Ha essite monistrate que varie hormoines ha u11 olo importante in le metabolismo de lipidos. Observationes clinic e experimienital implica le glandulas thyyroide, adrenal, gonadal, e pituitari in le atherogenese. Lc-indicios es le plus convincenite con respecto al rolo del estrogenos in le genese de atherosclerosis hunian. Le influentia de hypothyroidismo require studios additional e debe ancora esser clarifieate. Hormones e lipidos es obviemente non le sol factores de importantia in le atherogenese. Hypertension, local factores tissutal, e alteration del coagubation intravaseular exeree eoni alte grados de probabilitate un significative iiifluentia super le historia natural del niorbo.
